Articles by Arnaud Deladeriere

1. AI Is Not The CMC Revolution You're Looking For, And That's OK 11/18/2025

   Advanced therapy development today is less about big funding, more about frugality. Artificial intelligence unlocks a competitive advantage.

2. Should We Refocus On The Product, Then Engineer The Process? 10/14/2025

   Logic behind the "process is the product" refrain collapses when you accept that starting material is non-uniform by design. These experts want to rethink a tired cliche.

3. New Group Wants 'Phase-Appropriate' Thinking To Retire 9/4/2025

   Decisions in cell and gene therapy are not about aligning with arbitrary clinical phases but about balancing risk.